Ospraie Real Assets Fund reports a 19.9% stake in Ionetix
- Form
- Schedule 13G
- Filed
- Importance
- Routine
- Accession
- 0001213900-26-045673
Not explained yet; the original is on EDGAR.
Ownership stake disclosure by Ospraie Real Assets Fund LP
Similar companies
Same SIC code (2835) and public float not reported.
- Burzynski Research Institute BZYR
- Anbio Biotechnology NNNN
- Nymox Pharmaceutical NYMXF
- Asep Medical Holdings SEPSF
- Trinity Biotech TRIB